Barriers to optimizing inflammatory bowel disease care in the United States

被引:7
|
作者
Spencer, Elizabeth A. [2 ]
Abbasi, Sadeea [3 ]
Kayal, Maia [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, One Gustave L Levy Pl Box 1069, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol, New York, NY USA
[3] Cedars Sinai Santa Monica Gastroenterol, Div Gastroenterol, Santa Monica, CA USA
基金
美国国家卫生研究院;
关键词
barriers; inflammatory bowel disease; insurance; HEALTH-CARE; MANAGEMENT; GUIDELINE; THERAPY;
D O I
10.1177/17562848231169652
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Inflammatory Bowel Disease in Children
    Asha Jois
    George Alex
    Indian Journal of Pediatrics, 2024, 91 : 490 - 498
  • [32] Delivering inflammatory bowel disease care across distance
    Lim, Ming Han
    McMahon, Anna
    Radford-Smith, Graham
    INTERNAL MEDICINE JOURNAL, 2022, 52 (03) : 411 - 417
  • [33] Barriers to Respiratory Care Research in the United States
    Willis, L. Denise
    Rintz, Jacob
    Zaccagnini, Marco
    Miller, Andrew G.
    Li, Jie
    RESPIRATORY CARE, 2023, 68 (08) : 1112 - 1118
  • [34] Crossing barriers: the burden of inflammatory bowel disease across Western Europe
    Kumar, Aditi
    Yassin, Nuha
    Marley, Alexandra
    Bellato, Vittoria
    Foppa, Caterina
    Pellino, Gianluca
    Myrelid, Par
    Millan, Monica
    Gros, Beatriz
    Avellaneda, Nicolas
    Catalan-Serra, Ignacio
    El-Hussuna, Alaa
    Neves, Joo A. Cunha
    Roseira, Joana
    Cunha, Miguel F.
    Verstockt, Bram
    Bettenworth, Dominik
    Mege, Diane
    Brookes, Matthew J.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [35] Inflammatory bowel disease patients' expectations of care: Insights from a qualitative study
    Bednarikova, Hana
    Gabova, Kristyna
    Zelinkova, Zuzana
    Meier, Zdenek
    Tavel, Peter
    EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [36] Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000-2021
    Danpanichkul, Pojsakorn
    Pang, Yanfang
    Vuthithammee, Chawinthorn
    Dejvajara, Disatorn
    Dutta, Priyata
    Laoveeravat, Passisd
    Al Ta'ani, Omar
    Ho, Agnes HY.
    Pan, Chun Wei
    Tang, Nicole Shu Ying
    Suparan, Kanokphong
    Lui, Rashid N.
    Kim, Donghee
    Ng, Siew C.
    Kochhar, Gursimran Singh
    Farraye, Francis A.
    Wijarnpreecha, Karn
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [37] Optimizing treatment with thioguanine derivatives in inflammatory bowel disease
    Louis, E
    Belaiche, J
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (01) : 37 - 46
  • [38] Dietary intake patterns among adults with inflammatory bowel disease in the United States, 2015
    Xu, Fang
    Park, Sohyun
    Liu, Yong
    Greenlund, Kurt J.
    PLOS ONE, 2021, 16 (04):
  • [39] Quality of care in inflammatory bowel disease
    Shah B.
    Tinsley A.
    Ullman T.
    Current Gastroenterology Reports, 2011, 13 (1) : 87 - 94
  • [40] Trends and Characteristics of Clinical Trials Participation for Inflammatory Bowel Disease in the United States: A Report From IBD Partners
    Johnson, Cole
    Barnes, Edward L.
    Zhang, Xian
    Long, Millie D.
    CROHNS & COLITIS 360, 2020, 2 (02)